day 1 agenda
| 6th Edition of Innovations and State of the Art in ALZHEIMER'S & DEMENTIA at Oct 01 - 02, 2025 at Berlin, Germany (Hybrid Event) |
|
| Day -1(October 01, 2025) | |
| Tentative Program | |
| 09:00-09:30 | KeynoteTalk: Genistein (4′,5,7-trihydroxyisoflavone) corrects behavior and improves biochemical parameters in animal models of Alzheimer's disease through autophagy stimulation |
| Grzegorz Wegrzyn, University of Gdansk, Poland | |
| 09:30-10:00 | Slot Available |
| 10:00-10:30 | KeynoteTalk: Neurogenesis And Plasticity Processes Are Similarly Affected And Damaged In Alzheimer´s Disease |
| José Julio Rodríguez Arellano, IKERBASQUE, Spain | |
| Group Photo & Refreshment Break (10:30-10:50) | |
| Technical session-I | |
| 10:50-11:10 | Changes in expression of VGF, SPECC1L, HLA-DRA and RANBP3L act with APOE E4 to alter risk for late onset Alzheimer’s disease |
| Amanda J. Myers, University of Miami, USA | |
| 11:10-11:30 | Slot Available |
| 11:30-11:50 | A randomized feasibility trial of the modified Atkins diet in older adults with mild cognitive impairment due to Alzheimer’s disease |
| Alison Buchholz, The Johns Hopkins University School of Medicine, USA | |
| 11:50-12:10 | Cerebral Capillopathy Nexus of Neurodegenerative disease |
| Charles R Joseph, Liberty University College of Osteopathic Medicine, USA | |
| 12:10-12:30 | Slot Available |
| 12:30-12:50 | In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease |
| Paul Chazot, Durham University, UK | |
| Lunch Break @ Restaurant (12:50-13:40) | |
| 13:40-14:00 | Hearing Loss &Tinnitus – Reducing the Risk of Cognitive Decline |
| Keith N. Darrow, Worcester State University, USA | |
| 14:00-14:20 | Biological prognosis toolbox for Alzheimer’s disease and other cognitive neurodegenerative diseases |
| Marc Teichmann, PITIE SALPETRIERE, France | |
| 14:20-14:40 | One-week inpatient cognitive behavioral therapy for insomnia: a retrospective study |
| Qifang Li, Tongji university, China | |
| 14:40-15:00 | Slot Available |
| 15:00-15:20 | Dihydromyricetin as a Dual-Target Neuroprotector: Clearing Tau and Aβ for Alzheimer's Disease Intervention |
| Judy Qiao, Towncom International Group, USA | |
| 15:20-15:40 | Slot Available |
| 15:40:16:00 | Older adults with dementia:knowledge and attitudes of physicians in health units |
| ANA BEATRIZ QUINTES STEINER, UNIFESP, Brazil | |
| Refreshment Break(16:00-16:20) | |
| 16:20:16:40 | Three scenarios for amyloid transformation |
| Irena Roterman, Jagiellonian University – Medical College , Poland | |
| 16:40-17:00 | Slot Available |
| 17:00-17:20 | ‘Di-phenylalanine’ unit (FF) acts as the Nucleation site for beta-Amyloid Plaque Formation: Unraveling the Mechanisms of Alzheimer’s Disease |
| Raja Banerjee, MAKAUT, India | |
| Note: This is a Tentative program, subjects and timings will changes. | |
| Abstract submissions are open now. To schedule your talk in the program please email to: [email protected] | |
| Day-1 Concludes | |
day 2 agenda
Day 2 Program Will be updated soon.
posters agenda
| Poster Presentations | |
| PP-1 | In vitro validation of RARβ-M, Ellorarxine, for use in Alzheimers disease |
| Yunxi Zhang, Durham University, UK | |
| PP-2 | FUS-mediated Blood-brain barrier disruption for delivering anti-A? antibodies in 5XFAD Alzheimer’s disease mice |
| Christakis Damianou, Cyprus University of Technology, Cyprus | |
| PP-3 | Slot Available |
| PP-4 | Concussion-Related Biomarkers in Retired Rugby Players and Implications for Alzheimer’s Disease and ALS Risk: The UK Rugby Health Study |
| Yunxi Zhang, Durham University, UK | |
| PP-5 | Probing Monoclonal Antibody Specificity for Designing Alzheimer's Vaccines |
| Anne-Cathrine Vogt, University of Bern, Switzerland | |
| PP-6 | Slot Available |
| Abstract submissions are open now. To schedule your talk in the program please email to: [email protected] | |
posters agenda
| Tentative Program | |
| Day -1(October 01, 2025) | |
| Virtual Program | |
| 09:00-09:20 | CareWindow: Enhancing Communication for Seniors and Individuals with Disabilities |
| Zachary Bailey, Care Window, Australia | |
| 09:20-09:40 | Slot Available |
| 09:40-10:10 | Keynote Talk: Sex-specific brain protection in the clinical scenario: the case of davuentide |
| Illana Gozes, Tel Aviv University, Israel | |
| 10:10-10:30 | Metric and temporal relationships in collaborative map drawings |
| Bernard Guelton, Université Paris 1 Panthéon Sorbonne, France | |
| 10:30-10:50 | Slot Available |
| 10:50-11:10 | P re existing cognitive disorders and Long COVID neurocognitive sequelae : Why Do We Know So Little? |
| Caroline Jose,Vitalité Health Network, Canada | |
| 11:10-11:30 | Effects of intensive lifestyle changes on the progression of mild cognitive impairment or early dementia due to Alzheimer’s disease: a randomized, controlled clinical trial |
| Dean Ornish, Preventive Medicine Research Institute, USA | |
| 11:30-11:50 | Slot Available |
| 11:50-12:10 | Successes and Challenges: Insights from the first six months of the CONNECT program |
| Chitrali R. Mamlekar & Melissa A. Alunni, Misericordia University, USA | |
| 12:10-12:30 | Slot Available |
| 12:30-12:50 | Clinicians' Reluctance to Implement a Deeply Demented Patient's Advance Directive: A Broken Moral Compass |
| Norman L. Cantor, Retired from Rutgers University, USA | |
| 12:50-13:10 | Slot Available |
| 13:10-13:30 | An integrative review about electrophysiological biomarkers of cognitive impairment in Alzheimer’s disease: A developing relationship |
| Ezra C. Holston, University of Nevada Reno, USA | |
| 13:30-13:50 | Slot Available |
| 13:50-14:10 | Revised Criteria for Diagnosis and Staging of Alzheimer's Disease |
| Clifford R. Jack, Mayo Clinic, USA | |
| Day -2(October 02, 2025) | |
| Virtual Program | |
| 09:00-09:20 | A perspective on physical therapy approaches in motor function neurorehabilitation |
| Fengxue Qi, Beijing Sport University, China | |
| 09:20-09:40 | Slot Available |
| 09:40-10:00 | Students’ core self-evaluation, psychological capital, and academic engagement: A case study of Romania and Serbia |
| Elena Mirela Samfira, University of Life Sciences „King Mihai I” from Timisoara, Romania | |
| 10:00-10:20 | Slot Available |
| 10:20-10:40 | Passive exposure to novel stimuli drives neural adaptation that encodes stimulus statistics in songbird auditory forebrain |
| David S. Vicario, Rutgers University, USA | |
| 10:20-10:40 | Slot Available |
| 10:40-11:00 | Understanding Systems and Cognitive Process to Lead Change with Compassion |
| Elizabeth Wilhelm-Alderton & Renae Swanson, University of Wisconsin - Oshkosh, USA | |
| 11:00-11:20 | Slot Available |
| 11:20-11:40 | OXYGEN-OZONE THERAPY AND COGNITIVE FRAILTY: A NONPHARMACOLOGICAL APPROACH TO POTENTIALLY RESOLVE IMMUNE AND INFLAMMATORY DYSFUNCTIONS |
| Antonio Carlo Galoforo, University of Pavia, Italy | |
| 11:40-12:00 | Slot Available |
| 12:00-12:20 | Severe COVID-19 is associated with transcriptomic signatures of aging in the human brain |
| Maria Mavrikaki, Harvard Medical School, USA | |
| 12:20-12:40 | Slot Available |
| 12:40-13:00 | Psychosocial factors associated with the risk of developing psychosis in Mexico |
| Tecelli Domínguez Martínez, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñiz, Mexico | |
| 13:00-13:20 | Slot Available |
| 13:20-13:40 | How Children Learn To Understand Language Meanings |
| Stephen Grossberg, Boston University, USA | |
| 13:40-14:00 | Slot Available |
| Abstract submissions are open now. To schedule your talk in the program please email to: [email protected] | |